Maine (WABI) - After 61 days and approximately 4,200 miles, two men have made it to Maine to wrap up an epic journey. At the ...

The General Motors charity car show was held on Sunday in Cheshire, benefitting families with children diagnosed with Angelman Syndrome.

On June 27, Ultragenyx Pharmaceutical announced that the US FDA granted Breakthrough Therapy Designation for GTX-102 (apazunersen) as a treatment for Angelman syndrome.

Bike 4 Briar cyclists cross the country to support Angelman syndrome research The Bike for Briar team, consisting of Todd Downey and Charlie Nuck, is biking 4,200 miles across the U.S. and passed ...

The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 for Angelman syndrome, a severe neurodevelopmental disease, has been dosed by Ionis Pharmaceuticals, Inc ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the first participant has been dosed in the global Phase 3 REVEAL study, which is designed to evaluate the efficacy and safety of ...

In Your Neighborhood Cheshire car show supports kids with Angelman Syndrome In Your Neighborhood: News 8 visits WJMJ radiothon News 8 wins mini golf game at Travelers Championship ...

Poison hemlock has spread throughout the US. Here's how to kill it. How Mike Pence says he came to the conclusion he should ‘part ways’ with Trump ‘Final Destination: Bloodlines’ tops box ...

About MavriX Bio MavriX Bio is a biotechnology company dedicated to developing gene therapies for Angelman syndrome.